Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de estudo
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Food Chem Toxicol ; 44(6): 810-8, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16330140

RESUMO

Dietary modifications may significantly reduce cardiovascular disease (CVD) risk factors, including cholesterol and atherosclerosis. The present study addressed the effects of the crude extract from the pulp fruit of Tamarindus indica L. on lipid serum levels and early atherosclerotic lesions in hypercholesterolemic hamsters in vivo, and the extract's antioxidant action, in vitro. Animals were fed on either chow or atherogenic diet during 10 weeks and concomitantly received either water or T. indica L. extract for drinking. Treatment of hypercholesterolemic hamsters with the T. indica pulp fruit extract (5%) led to a decrease in the levels of serum total cholesterol (50%), non-HDL cholesterol (73%) and triglyceride (60%), and to an increase of high-density lipoprotein (HDL) cholesterol levels (61%). In vitro, the extract presented radical scavenging ability, as assessed by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and superoxide radicals assays, and led to decreased lipid peroxidation in serum, as assessed by the thiobarbituric acid reactive substances (TBARS) assay. In vivo, the extract improved the efficiency of the antioxidant defense system, as assessed by the superoxide dismutase, catalase and glutathione peroxidase activities. Together these results indicate the potential of tamarind extracts in diminishing the risk of atherosclerosis development in humans.


Assuntos
Antioxidantes/administração & dosagem , Frutas/química , Hipercolesterolemia/tratamento farmacológico , Hipolipemiantes/administração & dosagem , Fitoterapia , Extratos Vegetais/administração & dosagem , Animais , Aorta/patologia , Compostos de Bifenilo , Catalase/análise , Catalase/sangue , Colesterol/sangue , HDL-Colesterol/sangue , Cromatografia Líquida de Alta Pressão , Cricetinae , Dieta , Sequestradores de Radicais Livres , Glutationa Peroxidase/análise , Glutationa Peroxidase/sangue , Hipercolesterolemia/metabolismo , Hipercolesterolemia/patologia , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/enzimologia , Picratos , Superóxido Dismutase/análise , Superóxido Dismutase/sangue , Superóxidos , Tamarindus , Triglicerídeos/sangue , Aumento de Peso
2.
J Neurol Sci ; 156(2): 177-9, 1998 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-9588854

RESUMO

A 24-year-old male, who suffered since childhood from a progressive form of ataxia associated with peripheral neuropathy, was found severely deficient in serum vitamin E. He walked with bilateral aid and presented severe dysmetria of the limbs and dysarthric speech; muscular strength and trophism were slightly diminished in the distal muscles of four limbs and there was hypotonia of the arms; he presented absent deep tendon reflexes, bilateral Babinski's sign, reduced proprioception at four limbs, pes cavus and fasciculations of the tongue. Intestinal fat malabsorption and other gastrointestinal or haematological conditions associated with deficiency of this vitamin were ruled out. In this patient, after 2 years of a daily supplement of high doses of vitamin E, a further progression of the disease was not observed and, moreover, the neurophysiological characteristics of his neuropathy appeared clearly improved. A longitudinal evaluation of serum vitamin E levels showed values in the normal range after 13 months of therapy. The patient had molecular genetic analysis of chromosome 8 and was found homozygous for the unusual mutation 513insTT in the alpha-tocopherol transfer protein gene.


Assuntos
Ataxia/tratamento farmacológico , Doença de Refsum/tratamento farmacológico , Deficiência de Vitamina E/tratamento farmacológico , Administração Oral , Adulto , Ataxia/fisiopatologia , Ataxia/prevenção & controle , Suplementos Nutricionais , Humanos , Masculino , Doença de Refsum/fisiopatologia , Doença de Refsum/prevenção & controle , Vitamina E/uso terapêutico , Deficiência de Vitamina E/genética , Deficiência de Vitamina E/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA